Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Megatas-S 25mg Tablet
Manufacturer/Marketed By : INTAS PHARMACEUTICALS LTD
$4.08 $3.38
Megatas-S 25mg tablet is an antimuscarinic agent that contains an active ingredient called Mirabegron. This medicine reduces the activity and symptoms associated with an overactive bladder, such as urgency incontinence...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
MIRABEGRON
Active Pharmaceutical Ingredient
Megatas-S 25mg Tablet
4,08$
3,38$
Megatas-S 25mg tablet is an antimuscarinic agent that contains an active ingredient called Mirabegron. This medicine reduces the activity and symptoms associated with an overactive bladder, such as urgency incontinence (inability to control bladder emptying), sudden urination urges, and increased urinary frequency. This medicine is not advised to use in children under 18 years old. Megatas-S 25mg tablet should not be taken if you have allergies to Mirabegron or if you have high uncontrolled blood pressure. Before starting the treatment, inform your doctor if you have trouble emptying your bladder (urinary retention) or if you are taking specific medications for HIV, fungal or bacterial infections, or anticholinergic medicine. Don't consume this medicine if you are pregnant or planning to get pregnant or breastfeeding. Notify your doctor if you have liver or kidney problems. Your doctor may adjust your dose of Megatas-S 25mg tablet in such conditions. Also, inform your doctor if you have any heart conditions, such as abnormal ECG (QT prolongation) or taking medications that may cause it.
Active Pharmaceutical Ingredient
Uses
• Treatment of overactive bladder (OAB) symptoms.
• It helps to control uncontrollable bladder emptying (urgency incontinence).
• Reduce sudden urges to urinate.
• Reduce frequent urination.
Benefits
Megatas-S 25mg tablet works by stimulating beta-3 adrenergic receptors in the bladder, leading to the relaxation of the bladder muscles. This helps to increase bladder capacity and reduce urinary urgency and frequency.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Most Common Side Effects
• Increased heart rate
• Nausea
• Constipation
• Diarrhea
• Dizziness
• Urinary tract infection
Common Side Effects
• Irregular heartbeat
• Sudden or throbbing headache
• Angioedema (swelling of the face, mouth, or throat)
• Elevated blood pressure
How To Use
Take the Megatas-S 25mg tablet as your physician advises. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.
Safety Advice
• Breast Feeding: It is unsafe to use Megatas-S 25mg tablet during breastfeeding because the medicine may pass into breast milk. Consult your doctor for advice. Inform your doctor if you are breastfeeding.
• Alcohol: It is not known whether it is safe to drink alcohol while taking Megatas-S 25mg tablet. Check with your doctor for advice.
• Liver: Megatas-S 25mg tablet is used with caution in patients with liver impairment. Inform your physician about the pre-existing live conditions. Your physician will monitor your liver functions and adjust the dose accordingly.
• Lungs: It is unknown whether Megatas-S 25mg tablet is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
• Driving: It is unknown whether this medicine affects your ability to drive or use machines.
• Pregnancy: Megatas-S 25mg tablet is unsafe during pregnancy as it may harm the developing baby. Before starting the treatment, inform your doctor if you are pregnant or planning to get pregnant.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.